Skip to main content

XTL Biopharmaceuticals Ltd

XTLB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001023549

No open-market purchases or sales by XTL Biopharmaceuticals Ltd insiders were filed in the last 90 days; 3 institutions reported holding it in 13F filings for Q2 2026, worth $20.7K in total; no superinvestor holds it.

Members of Congress who traded XTLB

No member of Congress has reported a trade in XTL Biopharmaceuticals Ltd since 2020.

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report.